Sarepta Therapeutics Long Term Deferred Charges (Quarterly) Insights

Sarepta Therapeutics, Inc. (SRPT)

21.31 -0.21 (-0.98%) USD | NASDAQ | Jan 02, 16:00

21.40 +0.09 (+0.42%) Pre-Market: 09:15

View Long Term Deferred Charges (Quarterly) for SRPT.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Long Term Deferred Charges (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Long Term Deferred Charges (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Long Term Deferred Charges (Quarterly) Benchmarks

Start Trial

Pfizer Inc.	--
Arrowhead Pharmaceuticals, Inc.	--
Amgen, Inc.	--
Bristol Myers Squibb Co.	--
Alnylam Pharmaceuticals, Inc.	--